Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis.
Pozzilli C, Antonini G, Bagnato F, Mainero C, Tomassini V, Onesti E, Fantozzi R, Galgani S, Pasqualetti P, Millefiorini E, Spadaro M, Dahlke F, Gasperini C.
Pozzilli C, et al. Among authors: onesti e.
J Neurol. 2002 Jan;249(1):50-6. doi: 10.1007/pl00007847.
J Neurol. 2002.
PMID: 11954868
Clinical Trial.